Skip to main content
. 2022 Mar;11(2):106–119. doi: 10.21037/acs-2021-pte-10

Figure 6.

Figure 6

Proposed model illustrating the role of endothelial dysfunction in microvasculopathy associated with CTEPH. Dysfunction of the pulmonary endothelium leads to an altered balance of endothelium-derived vasoactive mediators including NO, endothelin-1 and prostacyclin. Other mediators such as cytokines, chemokines and growth factors may also contribute to pulmonary microvasculopathy. CTEPH, chronic thromboembolic pulmonary hypertension.